Related Experiment Video
Updated: May 13, 2025

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Coronary microcirculation in myocardial ischemia: A genetic perspective
Paolo Severino1, Andrea D'Amato1, Silvia Prosperi1
1Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
Genetic factors significantly influence coronary microvascular dysfunction (CMD), a key cause of ischemic heart disease (IHD). Understanding these genetic determinants, including SNPs, can lead to better diagnostics and personalized treatments for CMD.
Area of Science:
- Cardiology
- Genetics
- Vascular Biology
Background:
- Coronary microvascular dysfunction (CMD) significantly contributes to ischemic heart disease (IHD), independent of or alongside atherosclerosis.
- CMD involves structural and functional changes in the heart's microcirculation, leading to abnormal coronary blood flow.
- Pathological changes include microvascular remodeling, narrowing of arterioles and capillaries, perivascular fibrosis, and capillary rarefaction.
Purpose of the Study:
- To review the genetic determinants of coronary microvascular dysfunction (CMD).
- To focus on the role of genetic factors, such as single nucleotide polymorphisms (SNPs), in CMD.
- To explore the involvement of ion channels, microRNAs (miRNAs), and endothelial proteins in CMD genetics.
Main Methods:
- Literature review of genetic factors implicated in coronary microvascular dysfunction.
- Analysis of genetic variations (SNPs) affecting coronary blood flow and microcirculation.
- Examination of genetic influences on ion channels, miRNAs, and endothelial proteins relevant to CMD.
Main Results:
- Genetic factors, particularly SNPs, are crucial in the pathophysiology of CMD.
- Specific genes regulating coronary blood flow and microvascular structure are identified as key players.
- Ion channels, miRNAs, and endothelial proteins represent important genetic targets in CMD.
Conclusions:
- Genetic insights into CMD pathophysiology are advancing.
- This knowledge can facilitate the development of novel biomarkers for improved CMD diagnosis.
- Targeted, patient-tailored therapeutic strategies for CMD can be developed based on genetic understanding.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015